Medartis Holding AG

Medartis reports 13% revenue growth on Group level, driven by strong regional growth in the US (21%) and EMEA (18%) –improvement of EBITDA* margin to 17%

Basel, 9th July 2024   Matthias Schupp appointed as CEO of Medartis

Basel, 11th June 2024   Medartis announces resignation of CEO Christoph Brönnimann

Medartis successfully places CHF 115.8 million convertible bonds due 2031

Medartis launches senior convertible bond offering in a private placement of approximately CHF 115 million due 2031

Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16%